Specified speciality drugs from India and 19 other jurisdictions qualify for zero duty as the US extends its 100% pharma tariff to more companies; generics remain outside its scope
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.